{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:31:32Z","timestamp":1790724692272,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":4352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1046\/j.1469-0691.2003.00489.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:28:30Z","timestamp":1047367710000},"page":"15-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"title":["Microbial natural products as a source of antifungals"],"prefix":"10.1016","volume":"9","author":[{"given":"M.F.","family":"Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Basilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00489.x_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1126\/science.6337397","article-title":"New applications of microbial products","volume":"219","author":"Demain","year":"1983","journal-title":"Science"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/mr.50.3.259-279.1986","article-title":"Philosophy of new drug discovery","volume":"50","author":"Omura","year":"1986","journal-title":"Microbiol Rev"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib3","first-page":"1247","article-title":"Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980\u201390. National Nosocomial Infections Surveillance System","volume":"167","author":"Beck-Sague","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/clinids\/13.3.480","article-title":"The growing problem of mycoses in patients infected with the human immunodeficiency virus","volume":"13","author":"Diamond","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.8153622","article-title":"Human mycoses: drugs and targets for emerging pathogens","volume":"264","author":"Georgopapadakou","year":"1994","journal-title":"Science"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib6","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00002030-199715000-00008","article-title":"Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidiasis","volume":"11","author":"Carledge","year":"1997","journal-title":"AIDS"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib7","first-page":"2051","article-title":"Invasive fungal infections. Epidemiology and new therapies","volume":"29","author":"Granier","year":"2000","journal-title":"Presse Med"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib8","series-title":"The Yeasts","first-page":"199","article-title":"Cell walls","author":"Fleet","year":"1991"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib9","series-title":"Biotechnology of Antibiotics","first-page":"315","article-title":"Echinocandin antifungal agents","author":"Turner","year":"1997"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib10","first-page":"2459","article-title":"Metabolites of microorganisms. 143. Echinocandin B, a novel polypeptideantibiotic from Aspergillus nidulans var. echinulatus: isolation and structural components","volume":"57","author":"Nyfeler","year":"1974","journal-title":"Helv Chim Acta"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib11","series-title":"Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans","first-page":"104","article-title":"L-743,872, a novel antifungal lipopeptide: synthesis and structure-activity relationships of new aza-substituted pneumocandins. [abstract F27]","author":"Bouffard","year":"1996"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib12","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.7164\/antibiotics.45.1853","article-title":"Pneumocandins from Zalerion arboricola. I Discovery and isolation","volume":"45","author":"Schwartz","year":"1992","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S095375629800687X","article-title":"Reclassification of a pneumocandin-producing anamorph, Glarea lozoyensis gen. et sp. nov., previously identified as Zalerion arboricola","volume":"103","author":"Bills","year":"1999","journal-title":"Mycol Res"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm00028a003","article-title":"Synthesis and antifungal activity of novel cationic pneumocandin Bo derivatives","volume":"37","author":"Bouffard","year":"1994","journal-title":"J Med Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib15","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.41.11.2333","article-title":"Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis and cryptococcosis","volume":"41","author":"Abruzzo","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib16","series-title":"Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy New Orleans","first-page":"107","article-title":"Evaluation of pneumocandin L-743,872 in neutropenic mouse models of disseminated candidiasis and aspergillosis [abstract F41]","author":"Smith","year":"1996"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.42.8.1985","article-title":"Efficacy of MK-991 (L-743,872), a semisynthetic, pneumocandin, in murine models of Pneumocystis carinii","volume":"42","author":"Powles","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib18","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.45.6.1854-1859.2001","article-title":"Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model","volume":"45","author":"Gonz\u00e1lez","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib19","first-page":"939","article-title":"A randomized, double-blind, multicenter trial of MK-0991, an echinocandin antifungal agent, vs. amphotericin B for the treatment (Tx) of oropharyngeal (OPC) and esophageal (EC) candidiasis in adults","volume":"27","author":"Arathoon","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib20","series-title":"Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto","first-page":"371","article-title":"Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory R or Intolerant (I) to amphotericin B (AMB), AMB lipid formulations (lipid AMB), or azoles. [abstract J-1103]","author":"Maertens","year":"2000"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.45.2.471-479.2001","article-title":"Dosagedependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazol-resistant oropharyngeal and esophageal candidiasis","volume":"45","author":"Petraitis","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib23","unstructured":"Takashi T, Higashiimazato et al. Cyclic hexapeptides having antibiotic activity. International patent, WO 0064927, 2000."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib24","unstructured":"Aoki M, Kowada C et al. Aerothicin analogs, their preparation and use. International patent, WO 0005251, 2000."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7164\/antibiotics.40.275","article-title":"Mulundocandin, a new lipopentide antibiotic. I Taxonomy, fermentation, isolation and characterization","volume":"40","author":"Roy","year":"1987","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.7164\/antibiotics.53.1108","article-title":"Arborcandins A, B, C, D, E and F, novel 1, 3-\u03c6-glucan synthase inhibitors: production and biological activity","volume":"53","author":"Ohyama","year":"2000","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7164\/antibiotics.53.912","article-title":"FR901469, a novel antifungal antibiotic from an unidentified fungus no. 11243 I. Taxonomy, fermentation, isolation, physicochemical prpoerties and biological properties","volume":"53","author":"Fujie","year":"2000","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7164\/antibiotics.54.17","article-title":"New cyclic depsipeptide antibiotics, clavariopsins A and B, produced by an aquatic hyphomycete, Clavariopsis aquatica. I. Taxonomy, fermentation, isolation and biological properties","volume":"54","author":"Kaida","year":"2001","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7164\/antibiotics.30.289","article-title":"Papulacandins, a new family of antibiotics with antifungal activity. I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E","volume":"30","author":"Traxler","year":"1977","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0966-842X(00)88890-3","article-title":"The fungal cell wall as a drug target","volume":"3","author":"Georgopapadakou","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0960-894X(96)00113-8","article-title":"Preparation and antifungal activity of fusacandin analogs: C-6' sidechain esters","volume":"6","author":"Yeung","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","article-title":"Discovery of novel antifungal beta (1, 3)-glucan synthase inhibitors","volume":"44","author":"Onishi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s101230100020","article-title":"The discovery of arundifungin, a novel antifungal compound produced by fungi. Biological activity and taxonomy of the producing organisms","volume":"4","author":"Cabello","year":"2001","journal-title":"Int Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0723-2020(00)80062-4","article-title":"The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species. Biological activity and taxonomy of the producing organism","volume":"23","author":"Pel\u00e1ez","year":"2000","journal-title":"Syst Appl Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1365-2672.2001.01447.x","article-title":"Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum","volume":"91","author":"Vicente","year":"2001","journal-title":"J Appl Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib36","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1086\/317614","article-title":"The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans","volume":"182","author":"Feldmesser","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib37","first-page":"281","article-title":"Chitin biosynthesis in fungi","volume":"vol. 4","author":"Ruiz-Herrera","year":"1992"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.114.1.111","article-title":"The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle","volume":"114","author":"Shaw","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.35.1.170","article-title":"Differential inhibition of chitin synthetases 1 and 2 from Saccharomyces cerevisiae by polyoxin D and nikkomycins","volume":"35","author":"Gabib","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/AAC.29.3.389","article-title":"Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicans","volume":"29","author":"Hector","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib41","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.43.6.1401","article-title":"In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole","volume":"43","author":"Li","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/arch.940220118","article-title":"Chitin synthesis and degradation as targets for pesticide action","volume":"22","author":"Cohen","year":"1993","journal-title":"Arch Insect Biochem Physiol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.7164\/antibiotics.53.903","article-title":"Phellinsin A, a novel chitin synthesis inhibitor produced by Phellinus sp. Pl3","volume":"53","author":"Hwang","year":"2000","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib44","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1021\/jo960769n","article-title":"Arthrichitin. A new cell wall active metabolite from Arthrinium phaeospermum","volume":"61","author":"Vijayakumar","year":"1996","journal-title":"J Org Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7164\/antibiotics.51.303","article-title":"Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanium LL-15G256 II. Isolation and structure determination","volume":"51","author":"Schlingmann","year":"1998","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0304-4165(96)00067-0","article-title":"The retention mechanism of cell wall proteins in Sccharomyces cerevisiae. Wall bound Cwp2p is b1, 6-glucosylated","volume":"1291","author":"Van Der Vaart","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib47","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.7164\/antibiotics.41.1701","article-title":"Pradimicin, a novel class of potent antifungal anbiotics","volume":"41","author":"Oki","year":"1988","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7164\/antibiotics.41.807","article-title":"New antifungal antibiotics benanomicins A and B from an Actinomycete","volume":"41","author":"Takeuchi","year":"1988","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib49","first-page":"185","article-title":"Human mycoses and current antifungal therapy","volume":"11","author":"Fromtling","year":"1998","journal-title":"Drug News Perspect"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib50","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1016\/S0021-9258(17)44439-5","article-title":"The isolation and characterization of a mutant strain of Saccharomyces cerevisiae that requires a long chain base for growth and for synthesis of phosphosphingolipids","volume":"258","author":"Wells","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib51","doi-asserted-by":"crossref","first-page":"25032","DOI":"10.1016\/S0021-9258(19)74001-0","article-title":"Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase","volume":"267","author":"Zweerink","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7164\/antibiotics.48.349","article-title":"The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation and biological activity","volume":"48","author":"Mandala","year":"1995","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib53","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1101\/gad.10.4.382","article-title":"A ceramide-activated protein phosphatase mediates ceramide-induced G1 arrest of Saccharomyces cerevisae","volume":"10","author":"Nickels","year":"1996","journal-title":"Genes Dev"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib54","doi-asserted-by":"crossref","first-page":"13171","DOI":"10.1074\/jbc.270.22.13171","article-title":"Regulation of lipid biosynthesis in Saccharomyces cerevisiae by fumonisin B1","volume":"270","author":"Wu","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib55","doi-asserted-by":"crossref","first-page":"17376","DOI":"10.1074\/jbc.272.28.17376","article-title":"Suppresor gene analysis reveals an essential role for sphingolipids in transport of glycosylphosphatidylinositol-anchored proteins in Saccharomyces cerevisiae","volume":"272","author":"Oh","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib56","first-page":"376","article-title":"Sphingofungins E and F. Novel serine palmitoyltransferase inhibitors from Paecilomyces variotii","volume":"47","author":"Horn","year":"1992","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib57","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7164\/antibiotics.47.376","article-title":"Inhibition of serine palmitoyltransferase activity by lipoxamycin","volume":"47","author":"Mandala","year":"1994","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7164\/antibiotics.50.339","article-title":"Viridiofungins, novel inhibitors of sphingolipid synthesis","volume":"50","author":"Mandala","year":"1997","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib59","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1016\/S0021-9258(18)98712-0","article-title":"Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme","volume":"266","author":"Wang","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib60","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1074\/jbc.272.15.9809","article-title":"Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene","volume":"272","author":"Nagiec","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib61","doi-asserted-by":"crossref","first-page":"32709","DOI":"10.1074\/jbc.272.51.32709","article-title":"Khafrefungin, a novel inhibitor of sphingolipid synthesis","volume":"272","author":"Mandala","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib62","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1074\/jbc.273.24.14942","article-title":"Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase","volume":"273","author":"Mandala","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(00)11094-8","article-title":"Isolation and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungins, rustmicin, and khafrefungin","volume":"311","author":"Mandala","year":"2001","journal-title":"Meth Enzymol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib64","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7164\/antibiotics.45.861","article-title":"Sphingofungins A, B, C, and D; a new family of antifungal agents. I. Fermentation, isolation and biological activity","volume":"45","author":"VanMiddlesworth","year":"1992","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib65","first-page":"455","article-title":"Production, isolation, characterization, and evaluation of lipoxamycin, a new antifungal agent","volume":"10","author":"Whaley","year":"1970","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7164\/antibiotics.50.334","article-title":"Antimicrobial activity of viridiofungins","volume":"50","author":"Onishi","year":"1997","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib67","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.1995.1827","article-title":"Serine palmitoyltransferase is the primary target of a sphingosine.like immunosuppressant, ISP.1\/Myriocin","volume":"211","author":"Miyake","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib68","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7164\/antibiotics.44.919","article-title":"Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties","volume":"44","author":"Takesako","year":"1991","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib69","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.7164\/antibiotics.38.1806","article-title":"Rustmicin, a new macrolide antibiotic active against wheat stem rust fungus","volume":"38","author":"Takatsu","year":"1985","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib70","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.7164\/antibiotics.39.1760","article-title":"Galbonolides A and B- two non glycosidic antifungal macrolides","volume":"39","author":"Fauth","year":"1986","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib71","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7164\/antibiotics.51.837","article-title":"Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs","volume":"51","author":"Harris","year":"1998","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib72","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic","volume":"46","author":"Takesako","year":"1993","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib73","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.7164\/antibiotics.45.1697","article-title":"Screening assays for protein synthesis inhibitors","volume":"45","author":"Hall","year":"1992","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib74","doi-asserted-by":"crossref","first-page":"15423","DOI":"10.1016\/S0021-9258(19)84845-7","article-title":"Role of yeast Elongation Factor 3 in the Elongation Cycle","volume":"264","author":"Kamath","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib75","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0021-9258(17)40680-6","article-title":"Dissimilarity in chain elongation factor requirements between yeasts and rat liver ribosomes","volume":"252","author":"Skogerson","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib76","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/AAC.42.9.2274","article-title":"Sordarins: a new class of antifungal with selective inhibition of the protein synthesis elongation cycle in yeasts","volume":"42","author":"Dominguez","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib77","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1074\/jbc.273.6.3148","article-title":"Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis","volume":"273","author":"Justice","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01215185","article-title":"Translation elongation factor-3 (EF-3): an evolving eukaryotic ribosomal protein?","volume":"41","author":"Belfield","year":"1995","journal-title":"J Mol Evol"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib79","unstructured":"Sigg HP, Binningen Stoll C. Antibiotic SL, 2266. United States patent, US 3432598, 1969."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib80","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hlca.19710540427","article-title":"Isolierung und abbau von sordarin","volume":"54","author":"Hauser","year":"1971","journal-title":"Helv Chim Acta"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib81","unstructured":"Vasella A. Uber ein neuartiges diterpen aus Sordaria Araneosa Cain. PhD Thesis. Eidgen\u00f6 ssischen Technischen Hochschule, Z\u00fcrich., 1972."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib82","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1128\/AAC.42.9.2279","article-title":"Identification of elongation Factor 2 as the essential protein targeted by sordarins in Candida albicans","volume":"42","author":"Dominguez","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib83","unstructured":"Ogita T, Hayashi A, Sato S, Furaya K. Antibiotic zofimarin. Jpn Kokai Tokkyo Koho JP 6240292, 1987."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib84","unstructured":"Okada H, Kamiya S, Shiina Y et al. Antifungal substance BE-31405. Japanese patent JP 6157582, 1994."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib85","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.7164\/antibiotics.51.1081","article-title":"BE-31405, a new Antifungal Antibiotic produced by Penicillium minioluteum","volume":"51","author":"Okada","year":"1998","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib86","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.7164\/antibiotics.48.1171","article-title":"SCH 57404 an antifungal agent possessing the rare sordaricin skeleton and a tricyclic sugar moiety","volume":"48","author":"Coval","year":"1995","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib87","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10575639508043227","article-title":"Xylarin, an antifungal Xylaria metabolite with an unusual tricyclic uronic acid moiety","volume":"7","author":"Schneider","year":"1995","journal-title":"Natural products letters"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib88","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1515\/znc-1999-7-803","article-title":"Hypoxysordarin, a new sordarin derivative from","volume":"54c","author":"Daferner","year":"1999","journal-title":"Hypoxylon croceum Z Naturforsch"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib89","unstructured":"Martin JJ, Chicharro-Gonzalo J, G\u00f3mez JRR et al. Antifungal sordaridin derivatives. United States patent, US 6054478, 2000."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib90","unstructured":"Balkovec JM, Tse B et al. Sordarin derivatives. United States patent, US 6040463, 2000."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib91","unstructured":"Hirano A, Torigoe K, Ogawa H et al. Derivatives of antifungal substance BE-31405 and process for producing the same. United States patent, US 6087390, 2000."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib92","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7164\/antibiotics.51.41","article-title":"Isolation and characterisation of an antifungal antibiotic (GR 135402) with protein synthesis inhibition","volume":"51","author":"Kinsman","year":"1998","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib93","first-page":"297","article-title":"Sordarins as antifungal compounds","volume":"1","author":"Gargallo-Viola","year":"1999","journal-title":"Current Opinion Anti-Infective Investigational Drugs"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib94","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/AAC.44.5.1284-1290.2000","article-title":"In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marked compounds against Pneumocystic carinii isolated from rats","volume":"44","author":"Aviles","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib95","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/AAC.42.11.2863","article-title":"Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeast, Pneumocystis carinii, and filamentous fungi","volume":"42","author":"Herreros","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib96","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/AAC.43.7.1716","article-title":"Activities of sordarins in murine histoplasmosis","volume":"43","author":"Graybill","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib97","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/AAC.44.7.1874-1877.2000","article-title":"Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis","volume":"44","author":"Clemons","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib98","series-title":"Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto","first-page":"156","article-title":"In vivo activity of GM237354 in a neutropenic murine model of aspergillosis. [abstract F61]","author":"Oakley","year":"1997"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib99","series-title":"Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto","first-page":"389","article-title":"Preliminary toxicology of azasordarins. [abstract 1691]","author":"Herreros","year":"2000"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib100","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1128\/AAC.45.11.3132-3139.2001","article-title":"Antifungal activities and cytotoxicity studies of six new azasordarins","volume":"45","author":"Herreros","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib101","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00019048-199303000-00001","article-title":"therapy. past, present, and future","volume":"2","author":"Peacock","year":"1993","journal-title":"Infect Dis Clin Pract"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib102","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7164\/antibiotics.49.639","article-title":"UK-2A, B and C, novel antifungal antibiotics from Streptomyces sp. 517\u201302. Fermantation, isolation, and biological properties","volume":"49","author":"Ueki","year":"1996","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib103","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7164\/antibiotics.50.551","article-title":"UK-3A, a novel antifungal antibiotics from Streptomyces sp. 517\u201302. Fermantation, isolation, structural elucidation and biological properties","volume":"50","author":"Ueki","year":"1997","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1026552024021","article-title":"Screening of Basidiomycetes for antimicrobial activities","volume":"78","author":"Suay","year":"2000","journal-title":"Antonie Van Leeuwenhoek J Microbiology"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0953756297005662","article-title":"Endophytic fungi from plants living on gypsum soils as a source of secondary metabolites with antimicrobial activity","volume":"102","author":"Pel\u00e1ez","year":"1998","journal-title":"Mycol Res"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib106","unstructured":"Collado J, Gonz\u00e1lez del Val A, Platas G et al. Endophytic mycoflora from halophytes of the Ebro Delta (NE Spain). Screening of antimicrobial activities. In: International Symposium: Bioactive Fungal Metabolites\u2014Impact and Exploitation, Swansea. British Mycological Society, 2001; 4."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7164\/antibiotics.30.297","article-title":"Studies on aculeacin. I Isolation and characterization of aculeacin A","volume":"30","author":"Mizuno","year":"1977","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib108","unstructured":"Tscherter H, Dreyfuss MM. Antibiotics from a Cryptosporiopsis species and their therapeutic use. Sandoz S. A, Assignee Belg Patent, 889, 955, 1982."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib109","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0953-7562(09)80401-2","article-title":"An echinocandin from an endophytic Cryptosporiopsis sp. and Pezicula sp. in Pinus sylvestris and Fagus sylvatica","volume":"95","author":"Noble","year":"1991","journal-title":"Mycol Res"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib110","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1099\/13500872-145-8-1919","article-title":"Cryptocandin, a potent antimycotic from the endophytic fungus Cryptosporiopsis cf. Quercina","volume":"145","author":"Strobel","year":"1999","journal-title":"Microbiol UK"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib111","unstructured":"Hori Y. A novel series of antifungal lipopeptide antibiotics. In: The 14th Symposium of Kanto Branch of the Mycological Society of Japan Diversity of Fungal Metabolites, the Recent Topics and Future, Tokyo. Kanto Branch of the Mycological Society of Japan, 1999; 4."},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib112","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7164\/antibiotics.50.884","article-title":"Corynecandin: a novel antifungal glycolipid from Coryneum modonium","volume":"50","author":"Gunawardana","year":"1997","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib113","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7164\/antibiotics.46.247","article-title":"Mer-WF3010. A new member of the papulacandin family. I Fermentation, isolation and characterization","volume":"46","author":"Kaneto","year":"1993","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib114","doi-asserted-by":"crossref","first-page":"952","DOI":"10.7164\/antibiotics.46.952","article-title":"BU-4794F, a new \u03a6-1,3-glucan synthase inhibitor","volume":"46","author":"Aoki","year":"1993","journal-title":"J Antibiotics"},{"key":"10.1046\/j.1469-0691.2003.00489.x_bib115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7164\/antibiotics.44.45","article-title":"L-687,781, a new member of the papulacandin family of 1,3-d-glucan synthesis inhibitors. I. Fermentation, isolation and biological activity","volume":"44","author":"VanMiddlesworth","year":"1991","journal-title":"J Antibiotics"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14638337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14638337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:18:11Z","timestamp":1761117491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14638337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1198743X14638337"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00489.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial natural products as a source of antifungals","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00489.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}